Kainic acid (KA) is a neuroactive natural product from the red alga Digenea simplex. Its biosynthesis begins with DsKabA, an N-prenyltransferase that converts l-glutamate and dimethylallyl pyrophosphate into prekainic acid, the first committed intermediate. Here, we combined LC-MS activity assays, X-ray crystallography, SAXS, molecular docking, ITC, MD simulations, and mutagenesis to characterize DsKabA. Product analysis confirmed prekainic acid formation, and kinetic measurements yielded apparent Km values of 1.03 ± 0.16 μM for DMAPP and 52.25 ± 1.61 mM for l-Glu. The 2.85 Å apo structure revealed open and closed conformations involving the α7-loop-α8 region near the active site. Docking, ITC, and mutagenesis support Mg2+-dependent donor binding, ordered l-Glu association, and roles for Y403, H406, E407, M114, and M118 in catalysis and prenyl-donor recognition. These findings provide structural and mechanistic insight into the first committed step of KA biosynthesis.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: